These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 34274994)

  • 1. Hypermetabolism associated with worse prognosis of amyotrophic lateral sclerosis.
    He J; Fu J; Zhao W; Ren C; Liu P; Chen L; Li D; Tang L; Zhou L; Zhang Y; Ma X; Zhang G; Li N; Fan D
    J Neurol; 2022 Mar; 269(3):1447-1455. PubMed ID: 34274994
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypermetabolism in ALS is associated with greater functional decline and shorter survival.
    Steyn FJ; Ioannides ZA; van Eijk RPA; Heggie S; Thorpe KA; Ceslis A; Heshmat S; Henders AK; Wray NR; van den Berg LH; Henderson RD; McCombe PA; Ngo ST
    J Neurol Neurosurg Psychiatry; 2018 Oct; 89(10):1016-1023. PubMed ID: 29706605
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypermetabolism is a deleterious prognostic factor in patients with amyotrophic lateral sclerosis.
    Jésus P; Fayemendy P; Nicol M; Lautrette G; Sourisseau H; Preux PM; Desport JC; Marin B; Couratier P
    Eur J Neurol; 2018 Jan; 25(1):97-104. PubMed ID: 28940704
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hypermetabolism is a reality in amyotrophic lateral sclerosis compared to healthy subjects.
    Fayemendy P; Marin B; Labrunie A; Boirie Y; Walrand S; Achamrah N; Coëffier M; Preux PM; Lautrette G; Desport JC; Couratier P; Jésus P
    J Neurol Sci; 2021 Jan; 420():117257. PubMed ID: 33290920
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Factors Affecting Energy Metabolism and Prognosis in Patients with Amyotrophic Lateral Sclerosis.
    Kurihara M; Bamba S; Yasuhara S; Itoh A; Nagao T; Nakanishi N; Nakamura R; Ogawa N; Kitamura A; Yamakawa I; Kim H; Sanada M; Urushitani M; Sasaki M
    Ann Nutr Metab; 2021; 77(4):236-243. PubMed ID: 34515052
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic prediction by hypermetabolism varies depending on the nutritional status in early amyotrophic lateral sclerosis.
    Nakamura R; Kurihara M; Ogawa N; Kitamura A; Yamakawa I; Bamba S; Sanada M; Sasaki M; Urushitani M
    Sci Rep; 2021 Sep; 11(1):17943. PubMed ID: 34504168
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lower hypothalamic volume with lower body mass index is associated with shorter survival in patients with amyotrophic lateral sclerosis.
    Chang J; Shaw TB; Holdom CJ; McCombe PA; Henderson RD; Fripp J; Barth M; Guo CC; Ngo ST; Steyn FJ;
    Eur J Neurol; 2023 Jan; 30(1):57-68. PubMed ID: 36214080
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The hypometabolic state: a good predictor of a better prognosis in amyotrophic lateral sclerosis.
    Cattaneo M; Jesus P; Lizio A; Fayemendy P; Guanziroli N; Corradi E; Sansone V; Leocani L; Filippi M; Riva N; Corcia P; Couratier P; Lunetta C
    J Neurol Neurosurg Psychiatry; 2022 Jan; 93(1):41-47. PubMed ID: 34353859
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hypermetabolism in ALS patients: an early and persistent phenomenon.
    Bouteloup C; Desport JC; Clavelou P; Guy N; Derumeaux-Burel H; Ferrier A; Couratier P
    J Neurol; 2009 Aug; 256(8):1236-42. PubMed ID: 19306035
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Variation in Resting Metabolic Rate Affects Identification of Metabolic Change in Geographically Distinct Cohorts of Patients With ALS.
    Holdom CJ; Janse van Mantgem MR; He J; Howe SL; McCombe PA; Fan D; van den Berg LH; Henderson RD; van Eijk R; Steyn FJ; Ngo ST
    Neurology; 2024 Mar; 102(5):e208117. PubMed ID: 38350046
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Life course body mass index and risk and prognosis of amyotrophic lateral sclerosis: results from the ALS registry Swabia.
    Peter RS; Rosenbohm A; Dupuis L; Brehme T; Kassubek J; Rothenbacher D; Nagel G; Ludolph AC
    Eur J Epidemiol; 2017 Oct; 32(10):901-908. PubMed ID: 28975435
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypermetabolism in ALS: correlations with clinical and paraclinical parameters.
    Desport JC; Torny F; Lacoste M; Preux PM; Couratier P
    Neurodegener Dis; 2005; 2(3-4):202-7. PubMed ID: 16909026
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Factors correlated with hypermetabolism in patients with amyotrophic lateral sclerosis.
    Desport JC; Preux PM; Magy L; Boirie Y; Vallat JM; Beaufrère B; Couratier P
    Am J Clin Nutr; 2001 Sep; 74(3):328-34. PubMed ID: 11522556
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fat mass loss correlates with faster disease progression in amyotrophic lateral sclerosis patients: Exploring the utility of dual-energy x-ray absorptiometry in a prospective study.
    Lee I; Kazamel M; McPherson T; McAdam J; Bamman M; Amara A; Smith DL; King PH
    PLoS One; 2021; 16(5):e0251087. PubMed ID: 33956876
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Amyotrophic lateral sclerosis: a comparison of two staging systems in a population-based study.
    Ferraro D; Consonni D; Fini N; Fasano A; Del Giovane C; ; Mandrioli J
    Eur J Neurol; 2016 Sep; 23(9):1426-32. PubMed ID: 27238551
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early weight instability is associated with cognitive decline and poor survival in amyotrophic lateral sclerosis.
    Wei QQ; Ou R; Cao B; Chen Y; Hou Y; Zhang L; Wu F; Shang H
    Brain Res Bull; 2021 Jun; 171():10-15. PubMed ID: 33636227
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nutritional and metabolic factors in amyotrophic lateral sclerosis.
    Ludolph A; Dupuis L; Kasarskis E; Steyn F; Ngo S; McDermott C
    Nat Rev Neurol; 2023 Sep; 19(9):511-524. PubMed ID: 37500993
    [TBL] [Abstract][Full Text] [Related]  

  • 18. King's college progression rate at first clinical evaluation: A new measure of disease progression in amyotrophic lateral sclerosis.
    Introna A; Milella G; Morea A; Ucci M; Fraddosio A; Zoccolella S; D'Errico E; Simone IL
    J Neurol Sci; 2021 Dec; 431():120041. PubMed ID: 34736124
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognosis of amyotrophic lateral sclerosis with cognitive and behavioural changes based on a sixty-month longitudinal follow-up.
    Ye S; Jin P; Chen L; Zhang N; Fan D
    PLoS One; 2021; 16(8):e0253279. PubMed ID: 34379621
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Autonomic dysfunction is associated with disease progression and survival in amyotrophic lateral sclerosis: a prospective longitudinal cohort study.
    Dubbioso R; Provitera V; Pacella D; Santoro L; Manganelli F; Nolano M
    J Neurol; 2023 Oct; 270(10):4968-4977. PubMed ID: 37358634
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.